Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GENERATIONS: Arzoxifene in Postmenopausal Women with Osteoporosis
NCT00088010Phase 3Completed
- Sponsor
- Eli Lilly and Company
- Start
- Jun 2004
- Primary completion
- Jun 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of arzoxifene in osteoporosis, invasive breast cancer, sponsored by Eli Lilly and Company. Started Jun 2004; status: completed.
02
Drugs
arzoxifene
03
Conditions
osteoporosisinvasive breast cancer
Beyond the preview
Go deeper on NCT00088010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00088010.